Search Results - "Väänänen, R.M."

Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate by Stuopelyte, K., Sabaliauskaite, R., Bakavicius, A., Hafliidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

Get full text

P42 - Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate by Stuopelyte, K., Sabaliauskaite, R., Bakavicius, A., Hafliidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

Get full text

4 - Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer by Stuopelyte, K., Bakavicius, A., Sabaliauskaite, R., Haflidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

Get full text

Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer by Stuopelyte, K., Bakavicius, A., Sabaliauskaite, R., Haflidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

Get full text